GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Corline Biomedical AB (OSTO:CLBIO) » Definitions » Institutional Ownership

Corline Biomedical AB (OSTO:CLBIO) Institutional Ownership : 9.48% (As of Jun. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Corline Biomedical AB Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Corline Biomedical AB's institutional ownership is 9.48%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Corline Biomedical AB's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Corline Biomedical AB's Float Percentage Of Total Shares Outstanding is 0.00%.


Corline Biomedical AB Institutional Ownership Historical Data

The historical data trend for Corline Biomedical AB's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Corline Biomedical AB Institutional Ownership Chart

Corline Biomedical AB Historical Data

The historical data trend for Corline Biomedical AB can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 9.90 9.90 9.90 9.90 9.90 9.90 9.90 9.90 9.48 9.48

Corline Biomedical AB Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Corline Biomedical AB (OSTO:CLBIO) Business Description

Traded in Other Exchanges
N/A
Address
Lefflersgatan 5, Uppsala, SWE, 754 50
Corline Biomedical AB is involved in developing, manufacturing and marketing heparin-based solutions to improve kidney transplantation, cell therapies, and applications in the field of regenerative medicine.

Corline Biomedical AB (OSTO:CLBIO) Headlines

No Headlines